Law360, New York (October 27, 2009) -- Hoffmann-La Roche Inc. has won the reversal of a $7 million jury verdict in favor of a man who claimed he developed inflammatory bowel disease after taking the drugmaker's acne medication Accutane.
A Florida appeals court issued a per curiam order overturning the award on Tuesday, saying plaintiff Adam Mason had presented no evidence at his trial to support the claim that...
